Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-001286

Chief Technical Officer acquired 26,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Otero Jose Manuel · Chief Technical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-07 Grant or award : show line 1 in the form +26,250 57,500 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-07 Grant or award : show line 2 in the form Stock Option (right to buy) +52,500 52,500 D
Loading xslF345X05/form4-01102025_040108.xml…